Compound ID | 1873
Synonym(s): AAI101 | OCID 5090
Class: Beta-lactamase inhibitor (penicillanic acid sulfone)
Details of activity: | Binds irreversibly to beta-lactamases, mainly class A enzymes. No intrinsic antibacterial activity |
Combined with other compounds: | Yes |
Description: | Semisynthetic, derived from tazobactam, similar inhibition profiles to tazobactam. Only available as a combination product, fixed combination with cefepime |
Institute where first reported: | Orchid, Allecra |
Year first mentioned: | 1998 |
Highest developmental phase: | Approved by FDA in 2024 |
Development status: | Approved |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/23653540 |
Guide to Pharmacology: | enmetazobactam |
Citations: |
|